KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Common Equity (2016 - 2025)

LifeMD filings provide 14 years of Common Equity readings, the most recent being $23.2 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 406.54% to $23.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.2 million, a 406.54% increase, with the full-year FY2025 number at $23.2 million, up 406.54% from a year prior.
  • Common Equity hit $23.2 million in Q4 2025 for LifeMD, up from $1.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $23.2 million in Q4 2025 to a low of -$243.2 million in Q2 2025.
  • Median Common Equity over the past 5 years was -$3.5 million (2024), compared with a mean of -$13.7 million.
  • Biggest five-year swings in Common Equity: soared 1541.84% in 2022 and later crashed 12757.07% in 2025.
  • LifeMD's Common Equity stood at $21.7 million in 2021, then tumbled by 154.69% to -$11.9 million in 2022, then surged by 135.29% to $4.2 million in 2023, then plummeted by 280.33% to -$7.6 million in 2024, then skyrocketed by 406.54% to $23.2 million in 2025.
  • The last three reported values for Common Equity were $23.2 million (Q4 2025), $1.3 million (Q3 2025), and -$243.2 million (Q2 2025) per Business Quant data.